INTEGRITY IN WRITTEN AND VIDEO NEWS, featuring newsOS integration and a growing interactive community of interested and increasingly well-informed readers and viewers who help make us who we are… a truly objective news media resource with full disclosure of bias, fact-checking, voting, polling, ratings, and comments. Learn about our editorial policies and practices (below). Join us today by subscribing to either our FREE MEMBERSHIP plan, or our PLATINUM PAID SUBSCRIPTION plan; each plan offers an unparalleled suite of benefits to our subscribers. U.S. DAILY RUNDOWN:Your News, Your Voice.
Tag: Inflation Reduction Act
House Republicans Propose Cuts to Clean Energy Tax Credits Amidst Internal Party Divisions
In April 2025, House Republicans introduced a comprehensive tax reform bill that includes significant reductions to clean energy tax credits established under the Inflation Reduction Act (IRA) of 2022. This proposal has sparked considerable debate within the Republican Party, as some members express concerns over the potential economic and environmental impacts of such cuts.
Energy Policy at a Crossroads: Legal, Political, and Societal Tensions in a Shifting American Landscape
Energy policy has long been at the core of American economic, environmental, and geopolitical strategies. Today, against the backdrop of heightened climate urgency, volatile global energy markets, and a deeply polarized domestic political environment, the United States finds itself grappling with profound questions about the future direction of its energy governance. From regulatory battles over emissions standards to the legislative push for clean energy investments under the Inflation Reduction Act (IRA), energy policy is no longer merely a technical domain; it embodies the broader contest over constitutional authority, environmental stewardship, economic growth, and national security.
Trump Revives Boldest Drug Price Crackdown Yet: Inside the First Attempt to Peg U.S. Costs to Global Lows
The soaring cost of prescription drugs in the United States has long stirred public discontent and bipartisan concern. In April 2025, former President Donald J. Trump, now a leading candidate in the upcoming election cycle, signaled a renewed focus on this issue. According to a Reuters report (April 22, 2025), Trump is considering reintroducing international reference pricing (IRP) as a cost-control measure for U.S. drug prices. This policy, widely discussed during his first term and later blocked by federal courts, would benchmark U.S. drug prices against those paid in other wealthy nations like Sweden, Japan, and Canada.